6th February 2019
Drug Discovery News
Pathios Therapeutics and Sygnature Discovery sign strategic partnership
8th November 2018
Drug Discovery News
Sygnature Discovery announces multi-target drug discovery deal with Sitryx Therapeutics
15th August 2018
DMPK Drug Discovery News
Sygnature Discovery announces ambitious expansion plans with addition of Alderley Park facility
20th February 2018
Drug Discovery Therapeutic Areas
Sygnature Discovery’s medicinal chemists design improved agents against RSV infection
15th June 2017
Drug Discovery
Unlocking efficiency in drug discovery: GE Healthcare’s The Pulse visits Sygnature Discovery
2nd May 2017
Drug Discovery
Sygnature Discovery enhances Biophysics capability with addition of Biacore 8K SPR system
29th March 2017
Drug Discovery
Double celebration for TopiVert and Sygnature Discovery as two drug candidates begin clinical trials
1st February 2017
Drug Discovery Therapeutic Areas
Sygnature Discovery, Mironid®, and Peak Proteins to collaborate to discover new therapies for life-threatening and currently incurable kidney disease, ADPKD
13th January 2017
Drug Discovery
Pelago Bioscience and Sygnature Discovery collaborate to Provide CETSA® based Target Engagement Assays
13th October 2016
Drug Discovery
Sygnature is exhibiting at ELRIG’s Drug Discovery 2016 event at the ACC, Liverpool. Stand G1
5th October 2016
Drug Discovery Therapeutic Areas
Sygnature Discovery and Viramatix announce anti-viral drug discovery strategic alliance
20th July 2016
Drug Discovery
Sygnature Discovery’s drug discovery capabilities enhanced by acquisition of BMG LABTECH PHERAstar® FSX